Document ID: chunk:federal_register_of_legislation:F2025L00150:front:0:p6
Version: federal_register_of_legislation:F2025L00150
Segment Type: other
Provision Reference: 
Character Range: 15531–18878

24 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease:
         1.           amphetamines or amphetamine derivatives, including methamphetamine, 3, 4-methylenedioxymethamphetamine (Ecstasy or MDMA);
         2.           cocaine;
         3.           marijuana;
         4.           Khat and synthetic cathinones, including alpha-pyrrolidinopentiophenone, 4- methylmethcathinone (4-MMC), and 3-methylmethcathinone (3-MMC).
 4.       having an episode of acute cholinergic poisoning from exposure to an organophosphorus ester within the 1 week before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
Note: acute cholinergic poisoning and organophosphorus ester are defined in the Schedule 1 - Dictionary.
 1.       being exposed to:
         1.           an ambient temperature of 38 degrees Celsius or above; or
         2.           an ambient temperature of zero degrees Celsius or below;
for a period of at least 6 hours within the 1 week before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
 1.       being envenomated by a snake, scorpion, wasp, bee, hornet, spider, centipede, fish or jellyfish within the 24 hours before the clinical onset of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
 2.       having an acute hypersensitivity reaction (including anaphylaxis) involving the coronary arteries within the 12 hours before the clinical onset of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
 3.       having infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the 3 months before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) and sudden death from ischaemic heart disease;
Note 1: SARS-CoV-2 is the virus which causes coronavirus disease 2019 (COVID-19).
 1.       having influenza or a lower respiratory tract infection within the 30 days before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
 2.       being pregnant within the 6 weeks before the clinical onset or the clinical worsening of acute myocardial infarction or sudden death from ischaemic heart disease;
 3.       having a hypertensive emergency or crisis within the 24 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
Note: hypertensive emergency or crisis is defined in the Schedule 1 - Dictionary.
 1.       having atrial fibrillation or atrial flutter within the 30 days before the clinical onset of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
 2.       inability to obtain appropriate clinical management for ischaemic heart disease before clinical worsening.
 1.            Relationship to service
        1.           The existence in a person of any factor